Maesa José María, Fernández-Riejos Patricia, Mora Catalina Sánchez, de Toro María, Valladares Paloma Menéndez, González-Rodriguez Concepción
Clinic Biochemistry Department, Virgen Macarena University Hospital, Spain.
Pract Lab Med. 2016 May 14;5:57-64. doi: 10.1016/j.plabm.2016.05.002. eCollection 2016 Aug 1.
To evaluate the Bio-Rad D-100®, an HPLC analyzer for glycated hemoglobin (HbA) determination, and to compare its performance with the Menarini HA-8180V® and Sysmex G8®.
Method comparison was performed according to Clinical and Laboratory Standards Institute (CLSI) EP9-A2 guidelines. We selected 100 samples from the routine laboratory workload and analyzed them in duplicate with the three analyzers. The imprecision study was performed according to CLSI EP5-A2 guidelines for both inter-assay and intra-assay variability. Bias was assessed with external quality control material. To establish linearity, CLSI EP6-A protocol was followed.
Method comparison (95% confidence intervals in parentheses): D-100 vs G8: Passing-Bablok regression; y=0.973(0.963-0.983)×-0.07(-0.07-0.069); r=0.9989. Bland-Altman mean difference: -0.229%HbA (-0.256: -0.202); Relative bias plot: D-100/G8 vs D100-G8 mean ratio=0.971(0.967-0.975). D-100 vs HA-8180V: Passing-Bablok regression; y=0.944(0.932-0.958)×-0.078(0.024-0.173); r=0.9989. Bland-Altman mean difference: -0.363%HbA (-0.401: -0.325); Relative bias plot D-100/HA-8180V vs D100-HA-8180V mean ratio=0.955(0.952-0.958). Inter-assay coefficient of variation (CV): 0.81%. Intra-assay CV: 1.04% (low level), and 0.78% (high level). Bias against target value=2.332%. Linearity: r=0.998 in the concentration range 4.4-13.9%HbA. Carry-over: 0.0024%.
The Bio-Rad D-100 shows good correlation with G8 and HA-8180V. There is a small proportional systematic difference (2.7% and 5.6%, respectively) in both comparisons. Inter and intra-assay CVs are both lower than the lowest CV obtained in studies performed with D-100 and other instruments.
评估用于测定糖化血红蛋白(HbA)的高效液相色谱分析仪Bio-Rad D-100®,并将其性能与Menarini HA-8180V®和Sysmex G8®进行比较。
根据临床和实验室标准协会(CLSI)EP9-A2指南进行方法比较。我们从常规实验室检测样本中选取了100份样本,使用这三种分析仪进行双份检测。根据CLSI EP5-A2指南进行批间和批内精密度研究。使用外部质量控制材料评估偏差。按照CLSI EP6-A方案建立线性关系。
方法比较(括号内为95%置信区间):D-100与G8:Passing-Bablok回归;y = 0.973(0.963 - 0.983)× - 0.07(-0.07 - 0.069);r = 0.9989。Bland-Altman平均差异:-0.229%HbA(-0.256:-0.202);相对偏差图:D-100/G8与D100 - G8平均比值 = 0.971(0.967 - 0.975)。D-100与HA-8180V:Passing-Bablok回归;y = 0.944(0.932 - 0.958)× - 0.078(0.024 - 0.173);r = 0.9989。Bland-Altman平均差异:-0.363%HbA(-0.401:-0.325);相对偏差图D-100/HA-8180V与D100 - HA-8180V平均比值 = 0.955(0.952 - 0.958)。批间变异系数(CV):0.81%。批内CV:低水平为1.04%,高水平为0.78%。相对于靶值的偏差 = 2.332%。线性关系:在4.4 - 13.9%HbA浓度范围内r = 0.998。携带污染:0.0024%。
Bio-Rad D-100与G8和HA-8180V具有良好的相关性。在两项比较中均存在较小的比例系统差异(分别为2.7%和5.6%)。批间和批内CV均低于使用D-100和其他仪器进行的研究中获得的最低CV。